HD-OPM Archive
Topics › Statins

Statins may benefit chronic liver disease rather than harm it, per a review

Louis Nervegna · Jul 16, 2024 · ♥ 12 reactions · 12 comments · original Facebook post
StatinsWeight, visceral & liver fat
AI summary & key facts

A review of statin use in chronic liver disease and cirrhosis says statins, once feared as liver-harming, may beneficially affect cirrhosis, portal hypertension and liver cancer prevention. The authors stress randomized trials are still needed to confirm this.

Are statins harmful to the liver in the long term?

Newer evidence suggests the opposite.

Quoted:

“Statins were initially considered harmful agents for the liver, but current evidence now suggests that this drug class may have beneficial effects in some CLD [Chronic Liver Diseases] as well as a potentially positive impact on the natural history and complications of cirrhosis. However, prospective interventional studies and randomized trial need to be carried out to confirm these observations. If the benefits of statins in CLD are confirmed, hepatologists will achieve better outcomes in their patients without significant additional costs.”

“Chronic liver disease (CLD), cirrhosis, and its complications, including hepatocellular carcinoma (HCC), are significant public health problems. The use of statins in patients with CLD has been a matter of concern, and physicians are often reluctant to its prescription in these patients. This mainly relates to the potential occurrence of drug-induced liver injury. However, newer evidence from pre-clinical and clinical research has shown that statins are drugs with a potentially beneficial impact on the natural history of cirrhosis, on portal hypertension, and in HCC prevention.”

#statinsliverHD #liverHD #statinsHD

Paper · Curr Gastroenterol Rep · 2017Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.The purpose of this study is to analyze the current evidence regarding the use of statins in patients with chronic liver disease and cirrhosis. Chronic liver disease (CLD), cirrhosis, and its complications, including hepatocellular carcinoma (HCC), are significant public health problems. The use of statins in patients with CLD has been a matter of concern, and physicians are often reluctant to its prescription in…ncbi.nlm.nih.gov

Research cited

← newer: AHA patient guide to cholesterol-lowering medicationsolder: Video on what the Lyon, PREDIMED and CORDIOPREV Mediterranea →